Revenue Growth Momentum
DGX grew total revenue to $2,895M in Q1 FY2026, up 9.2% from $2,652M in the prior-year period, reflecting continued demand for diagnostic and laboratory services.
QUEST DIAGNOSTICS INC is expected to release its Q2 2026 10-Q filing in the upcoming earnings season. Last quarter: DGX delivered solid Q1 FY2026 results with revenue of $2.90B (+9.2% YoY) and net income of $252M (+14.5% YoY), driven by operating leverage that expanded operating margin to 13.8%.
Drawn from management commentary in the Q1 2026 10-Q:
DGX grew total revenue to $2,895M in Q1 FY2026, up 9.2% from $2,652M in the prior-year period, reflecting continued demand for diagnostic and laboratory services.
Operating income rose 15.3% YoY to $399M, outpacing revenue growth and expanding operating margin by approximately 73 basis points to 13.8%, suggesting cost discipline relative to top-line growth.
Net income increased 14.5% YoY to $252M, with diluted EPS rising 15.5% to $2.24 from $1.94, reflecting both earnings growth and the benefit of share count management.
Revenue
$2.9B
++9.16% YoY
EPS (Basic)
$2.27
++15.23% YoY
Operating Income
$399M
++15.32% YoY
Add DGX to your watchlist to get the AI analysis in your inbox within minutes of the 10-Q filing.